Paperpal Prime Logo

JOURNAL OF HEPATOCELLULAR CARCINOMA : Impact Factor & More

eISSN: 2253-5969pISSN: 2253-5969
JournalOpen Access

Key Metrics

Eigenfactor
< 0.001
Impact Factor
< 5
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on JOURNAL OF HEPATOCELLULAR CARCINOMA

JOURNAL OF HEPATOCELLULAR CARCINOMA Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in JOURNAL OF HEPATOCELLULAR CARCINOMA ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in JOURNAL OF HEPATOCELLULAR CARCINOMA

PTM-Related Signatures Predict Lymph Node Metastasis and Shape Microenvironment in Hepatocellular Carcinoma: A Single-Cell and Bulk Integrated Analysis
  • 29 Jul 2026
  • Journal of Hepatocellular Carcinoma
Giant Atypical Hepatocellular Adenoma of Unknown Etiology in a Young Male: A Case Report
  • 27 Jul 2026
  • Journal of Hepatocellular Carcinoma
Metabolic Reprogramming-Targeted Therapeutic Strategies in Primary Liver Cancer: A Bibliometric and Visualized Analysis
  • 22 Jul 2026
  • Journal of Hepatocellular Carcinoma
Prognostic Significance of Combined \u03b1-Fetoprotein and PIVKA-II for Hepatocellular Carcinoma After Hepatectomy
  • 22 Jul 2026
  • Journal of Hepatocellular Carcinoma
Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
  • 17 Jul 2026
  • Journal of Hepatocellular Carcinoma
Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)
  • 16 Jul 2026
  • Journal of Hepatocellular Carcinoma
PTM-Related Signatures Predict Lymph Node Metastasis and Shape Microenvironment in Hepatocellular Carcinoma: A Single-Cell and Bulk Integrated Analysis
  • 29 Jul 2026
  • Journal of Hepatocellular Carcinoma
Giant Atypical Hepatocellular Adenoma of Unknown Etiology in a Young Male: A Case Report
  • 27 Jul 2026
  • Journal of Hepatocellular Carcinoma
Metabolic Reprogramming-Targeted Therapeutic Strategies in Primary Liver Cancer: A Bibliometric and Visualized Analysis
  • 22 Jul 2026
  • Journal of Hepatocellular Carcinoma
Prognostic Significance of Combined \u03b1-Fetoprotein and PIVKA-II for Hepatocellular Carcinoma After Hepatectomy
  • 22 Jul 2026
  • Journal of Hepatocellular Carcinoma
Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
  • 17 Jul 2026
  • Journal of Hepatocellular Carcinoma
Adjuvant Sintilimab Plus Bevacizumab After Curative Resection of Spontaneously Ruptured Hepatocellular Carcinoma: Protocol for a Prospective, Exploratory, Single-Arm Study (CLEAR-2)
  • 16 Jul 2026
  • Journal of Hepatocellular Carcinoma

FAQs on JOURNAL OF HEPATOCELLULAR CARCINOMA